Targeting of Interferon-Beta to Produce a Specific, Multi-Mechanistic Oncolytic Vaccinia Virus

por Kirn, David H, Wang, Yaohe, Le Boeuf, Fabrice, Bell, John, Thorne, Steve H
Publicado 2007

The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)

por Breitbach, Caroline J, Bell, John C, Hwang, Tae-Ho, Kirn, David H, Burke, James
Publicado 2015

Oncolytic virotherapy for advanced liver tumours

por Chang, Ju-Fang, Chen, Pei-Jer, Sze, Daniel Y, Reid, Tony, Bartlett, David, Kirn, David H, Liu, Ta-Chiang
Publicado 2009

Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing

por Inoue, Tomoyoshi, Byrne, Thomas, Inoue, Mitsuko, Tait, Madeline E., Wall, Patrick, Wang, Annabel, Dermyer, Michael R., Laklai, Hanane, Binder, Joseph J., Lees, Clare, Hollingsworth, Robert, Maruri-Avidal, Liliana, Kirn, David H., McDonald, Donald M.
Publicado 2021

The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers

por Parato, Kelley A, Breitbach, Caroline J, Le Boeuf, Fabrice, Wang, Jiahu, Storbeck, Chris, Ilkow, Carolina, Diallo, Jean-Simon, Falls, Theresa, Burns, Joseph, Garcia, Vanessa, Kanji, Femina, Evgin, Laura, Hu, Kang, Paradis, Francois, Knowles, Shane, Hwang, Tae-Ho, Vanderhyden, Barbara C, Auer, Rebecca, Kirn, David H, Bell, John C
Publicado 2012